Exxon Mobil Corp (XOM) on Tuesday announced it will cut planned capital spending by 30% this year as the coronavirus pandemic outbreak curtails …
Balyasny Asset Management’s Dmitry Balyasny has adjusted some crucial stocks in the fund’s portfolio in Q1. Here we examine his latest moves on …
Recently, various executives have taken part in insider trading activity in Valeant Pharmaceuticals Intl Inc (NYSE:VRX), American Airlines Group Inc (NASDAQ:AAL), and Starbucks Corporation (NASDAQ:SBUX). Let’s …
In a research report released today, Oppenheimer analyst Jason Helfstein reiterated an Outperform rating on shares of Baidu Inc (ADR) (NASDAQ:BIDU), while raising the …
Canaccord analyst Neil Maruoka weighed in today with his views on Valeant Pharmaceuticals Intl Inc (NYSE:VRX), as the company will report unaudited fourth-quarter financial results on …
In a research report issued Thursday, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on shares of Keryx Biopharmaceuticals (NASDAQ:KERX), while slashing the price …
Tuesday turned out to be a nightmare for shareholders of PTC Therapeutics, Inc. (NASDAQ:PTCT) as the stock price tumbled over 55%, after the biotech company received …
Cowen’s healthcare analyst Boris Peaker weighed in today on biotech firm Heron Therapeutics Inc (NASDAQ:HRTX), following the company’s fourth-quarter financial results and update on its clinical …
Canaccord’s healthcare analyst Neil Maruoka weighed in on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), after the company announced the finalization of a co-promotion agreement …
In a research report issued Wednesday, Canaccord analyst Alex Brooks reiterated a Sell rating on shares of Seadrill Ltd (NYSE:SDRL), with a price target of …
